longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

Co-Diagnostics

CODX

1.1200.00% ( 0.000 )
Closed: Sep 9, 16:00:00 (EDT)
Start trading
OverviewOverviewOptionsOptionsNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI

Current ValuationThe current P/E ratio is -0.17, within the reasonable range, cheaper than 34.23% of the time in the past 5 years, and the industry ranks 56/175, the industry Median -0.95.

-0.166xP/E
$1.12Stock price
$-6.74Earnings per share
-0.166xP/E
Stock price$1.12Earnings per share$-6.74

Historical Valuation

P/E ratioTypical rangeMedian
P/E ratio
-0.39x
Typical range
-1.04x–4.49x

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
010203040

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
0x30x60x90x120x150x
P/E ratio
Name/Symbol
BAXUSBaxter
-12.09x141.71%$12.85B
GKOSUSGlaukos
-58.04x75.34%$10.91B
TFXUSTeleflex
-5.63x118.39%$5.81B
IRTCUSIRhythm
-288.91x71.96%$4.03B
PLSEUSPulse Biosciences
-43.47x27.55%$3.48B
AXGNUSAxogen
-74.82x23.53%$2.51B
BFLYUSButterfly Network
-26.75x34.41%$2.00B
NVCRUSNovocure
-13.21x2.52%$1.96B
ASSTUSStrive
-1.93x63.26%$1.88B
KMTSUSKestra Medical Tech
-11.41x5.19%$1.50B
ATECUSAlphatec
-12.90x41.67%$1.42B
TNDMUSTandem Diabetes
-21.85x77.82%$1.38B
DRTSUSAlpha Tau Medical
-14.80x--$1.37B
IARTUSIntegra LifeSciences
-174.74x109.50%$1.27B
AORTUSArtivion
-383.97x266.67%$1.23B
PRCTUSPROCEPT BioRobotics
-11.14x3.47%$1.22B
ENOVUSEnovis
-1.05x100.97%$1.15B
CBLLUSCeribell
-14.14x35.15%$932.97M
QDELUSQuidelOrtho
-0.88x75.33%$917.54M
BBNXUSBeta Bionics
-11.92x17.96%$869.65M

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.